Rojo-Gutiérrez MI, Herrera-Sánchez DA, Mellado-Ábrego J, Castillo-Narváez G, Ramos-García JA

Language: Spanish
References: 23
Page: 141-146
PDF size: 152.13 Kb.

ABSTRACT

Introduction. Allergic rhinitis (AR) and asthma are common diseases that often coexist. In our country is low prevalence and high mortality of asthma, associated with subdiagnostic, and minimization of illnesses associated. Objective. Assess diagnostic errors more frequent in sending to specialty of allergy. Material and methods. It is a transversal, observational, retrospective study. They were reviewed 2,048 expedients first time consultation of allergy, comparing allergist’s diagnosis with sending’s diagnostic. Results. 1,924 expedients were analyzed that met our inclusion criteria, 1113 (58%) female and male 811 (42%). Age range between 0-10 years (37%), 11-20 years (2)0% and finally 31-40 years (12.8%). Average age 21.68, mode 8 years old. Sending’s diagnosis: AR with 44%, asthma 18%, urticaria 5.5%; AR + asthma (4.1%), atopic dermatitis (2.4%) and other diagnostics (24%); allergy diagnostics were: RA (34%), asthma (7.6%), urticaria (8.6%); RA + asthma (27.1%), atopic dermatitis (2.4%) and other diagnoses (19%), the correlation between the diagnoses was 56%. Specialties with not concordant diagnoses were: General medicine (80%), Emergency of Adults (60%), Pediatrics (56%), ORL (44%), Pneumology and Internal Medicine 28%, Ophthalmology (21%) and Dermatology (11%). The discrepancies with other hospitals fluctuate between 29 and 90%. AR is sub diagnosed mainly when is associated with asthma, this is because there is still lack of knowledge by the MPh of diagnostic criteria of allergic diseases.

REFERENCES

1. López G. Prevalencia de las enfermedades alérgicas de la Ciudad de México. Alergia México 2009; 56: 72-9.

2. Fanta C. Asthma. N Eng J Med 2009; 14: 1002-14.

3. Global strategy for asthma management and prevention. Global iniciative for asthma. 2009.

4. Sidney S. Global burden of asthma. Chest 2006; 130: 130-42.

5. Burney P. The Changing prevalence of asthma. Thorax 2002; 57: 36-9.

6. Christopher L. Variation in the prevalence and severity of asthma symptoms: Phase Three ISAAC. Thorax 2009; 25: 123-9.

7. Neffen H. Asthma Control in Latin America: the asthma insights a reality in Latin America (AIRLA). Rev Panam Sal Pub 2005; 3: 191-7.

8. Vargas M. Epidemiología del asma. Neumología y tórax 2009; 68: 91-97, 203-18.

9. Khaled It. Map of the prevalence of symptoms of rhinoconjuntivitis in children: ISAAC Phase III. Alergy 2009; 64: 123-48.

10. López G. Factores de riesgo relacionados con enfermedades alérgicas en la Ciudad de México. Alergia de México 2009; 51: 204-16.

11. Torres I. Prevalencia de asma en adolescentes. Relación con el sexo y tabaquismo activo. Alergia México 2010; 5: 146-52.

12. Rojo. Epidemiología del asma. NEJM 2009; 20: 14-6.

13. Rojo MI. Epidemiología del asma. 2011. J Med 2011; 4: 55-6.

14. Márquez. Fisiopatología. Alergia de México 2011; 12: 20-5.

15. Roa F. Estimaciones sobre la tendencia del asma en México para el periodo 2008-2012. An Med 2009; 54: 16-22.

16. Dirección de prestaciones Médicas IMSS. Guía para el diagnóstico, estadificación y tratamiento del asma. IMSS; 2009, pp. 1-64.

17. Bahadori K. A systematic review of economic evaluations of therapy in asthma. Journal of asthma and allergy 2010; 3: 33-42.

18. Del Río B. Rinitis, sinusitis y alergia. Alergia México 2009; 6: 201-16.

19. Dinark C. The Yellow zone in asthma treatment: is it a grey zone? Ann Allergy Asthma Inmunol 2004; 92: 7-16.

20. Rabe F. Worldwide severity and control of asthma in children and adults. J Allergy Clin Inmunol 2004; 114: 40-7.

21. Baena C. Actualización de la RA y su impacto en el asma (ARIA 2008). Alergia México 2009; 2: 146-52.

22. Bousquet J. Allergic Rhinitis and its impact on asthma (ARIA) 2008. Allergy 2008; 63: 8-16.

23. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality survey. Immunol J Allergy Clin 2004; 1: 40-7.